Protective effect of ellagic acid on concanavalin A-induced hepatitis via toll-like receptor and mitogen-activated protein kinase/nuclear factor κb signaling pathways

Journal of Agricultural and Food Chemistry

Volumn 62, Issue 41, 2014, Pages 10110-10117

  Lee, Jae Hong ^a   Won, Jong Hoon ^a   Choi, Jong Min ^a   Cha, Hye Hyeon ^a   Jang, Yeo Jin ^a   Park, Seohyeon ^a   Kim, Han Gyeol ^a   Kim, Hyung Chul ^a   Kim, Dae Kyong ^a  

^a Chung Ang University   (South Korea)

Author keywords

concanavalin A; ellagic acid; hepatitis; mitogen activated protein kinase; nuclear factor B; toll like receptors

Indexed keywords

CONCANAVALIN A; HEPATITIS; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTORS; TOLL-LIKE RECEPTORS;

ELLAGIC ACID;

CONCANAVALIN A; ELLAGIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTECTIVE AGENT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; GENETICS; HEPATITIS; HUMAN; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CONCANAVALIN A; ELLAGIC ACID; HEPATITIS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHORYLATION; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84908052270     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf503188c     Document Type: Article

References (47)

1. Ajuebor, M. N.; Carey, J. A.; Swain, M. G. CCR5 in T cell-mediated liver diseases: What's going on? J. Immunol. 2006, 177 (4) 2039-2045
2. Tiegs, G.; Hentschel, J.; Wendel, A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A J. Clin. Invest. 1992, 90 (1) 196-203
3. Ojiro, K. MyD88-dependent pathway accelerates the liver damage of concanavalin A-induced hepatitis Biochem. Biophys. Res. Commun. 2010, 399 (4) 744-749
4. Cao, Q. Y. A microarray analysis of early activated pathways in concanavalin A-induced hepatitis J. Zhejiang Univ., Sci., B 2010, 11 (5) 366-377
5. Tu, C. T. Curcumin attenuates concanavalin A-induced liver injury in mice by inhibition of toll-like receptor (TLR)2, TLR4 and TLR9 expression Int. Immunopharmacol. 2012, 12 (1) 151-157
6. Chen, Y.; Sun, R. Toll-like receptors in acute liver injury and regeneration Int. Immunopharmacol. 2011, 11 (10) 1433-1441
7. Soares, J. B. Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence Innate Immun. 2012, 18 (5) 700-708
8. Berzsenyi, M. D. Hepatic TLR2 and TLR4 expression correlates with hepatic inflammation and TNF-α in HCV and HCV/HIV infection J. Viral Hepatitis 2011, 18 (12) 852-860
9. Xu, J. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury J. Immunol. 2011, 187 (5) 2626-2631
10. Bourke, E. The toll-like receptor repertoire of human B lymphocytes: Inducible and selective expression of TLR9 and TLR10 in normal and transformed cells Blood 2003, 102 (3) 956-963
11. Bosisio, D. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: A molecular basis for priming and synergism with bacterial lipopolysaccharide Blood 2002, 99 (9) 3427-3431
12. Kadowaki, N. Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J. Exp. Med. 2001, 194 (6) 863-869
13. Muzio, M. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells J. Immunol. 2000, 164 (11) 5998-6004
14. Schwabe, R. F.; Seki, E.; Brenner, D. A. Toll-like receptor signaling in the liver Gastroenterology 2006, 130 (6) 1886-1900
15. Akira, S.; Uematsu, S.; Takeuchi, O. Pathogen recognition and innate immunity Cell 2006, 124 (4) 783-801
16. Seki, E.; Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: Update Hepatology 2008, 48 (1) 322-335
17. Akira, S.; Takeda, K. Toll-like receptor signalling Nat. Rev. Immunol. 2004, 4 (7) 499-511
18. Antosz, H.; Choroszynska, D. Negative regulation of toll-like receptor signalling Postepy Hig. Med. Dosw. 2013, 67, 339-350
19. Suzuki, N. Ellagic acid inhibits pancreatic fibrosis in male Wistar Bonn/Kobori rats Dig. Dis. Sci. 2009, 54 (4) 802-810
20. Chao, P. C.; Hsu, C. C.; Yin, M. C. Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice Nutr. Metab. 2009, 6, 33
21. Rogerio, A. P. Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma Eur. J. Pharmacol. 2008, 580 (1-2) 262-270
22. Bell, C.; Hawthorne, S. Ellagic acid, pomegranate and prostate cancer - A mini review J. Pharm. Pharmacol. 2008, 60 (2) 139-144
23. Falsaperla, M. Support ellagic acid therapy in patients with hormone refractory prostate cancer (HRPC) on standard chemotherapy using vinorelbine and estramustine phosphate Eur. Urol. 2005, 47 (4) 449-454
24. Hwang, J. M. Ellagic acid protects hepatocytes from damage by inhibiting mitochondrial production of reactive oxygen species Biomed. Pharmacother. 2010, 64 (4) 264-270
25. Bozza, M. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice Hepatology 1999, 30 (6) 1441-1447
26. Atessahin, A. Modulatory effects of lycopene and ellagic acid on reproductive dysfunction induced by polychlorinated biphenyl (Aroclor 1254) in male rats Basic Clin. Pharmacol. Toxicol. 2010, 106 (6) 479-489
27. Girish, C.; Pradhan, S. C. Hepatoprotective activities of picroliv, curcumin, and ellagic acid compared to silymarin on carbon-tetrachloride-induced liver toxicity in mice J. Pharmacol. Pharmacother. 2012, 3 (2) 149-155
28. Singh, K.; Jaggi, A. S.; Singh, N. Exploring the ameliorative potential of Punica granatum in dextran sulfate sodium induced ulcerative colitis in mice Phytother. Res. 2009, 23 (11) 1565-1574
29. Kaneko, Y. Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis J. Exp. Med. 2000, 191 (1) 105-114
30. Cameron, A. R.; Nelson, J.; Forman, H. J. Depolarization and increased conductance precede superoxide release by concanavalin A-stimulated rat alveolar macrophages Proc. Natl. Acad. Sci. U. S. A. 1983, 80 (12) 3726-3728
31. Boldt, D. H.; MacDermott, R. P.; Jorolan, E. P. Interaction of plant lectins with purified human lymphocyte populations: Binding characteristics and kinetics of proliferation J. Immunol. 1975, 114 (5) 1532-1536
32. Rajesh, M. G.; Latha, M. S. Preliminary evaluation of the antihepatotoxic activity of Kamilari, a polyherbal formulation J. Ethnopharmacol. 2004, 91 (1) 99-104
33. Volarevic, V. Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice Hepatology 2012, 55 (6) 1954-1964
34. Itoh, A. Hepatoprotective effect of syringic acid and vanillic acid on concanavalin A-induced liver injury Biol. Pharm. Bull. 2009, 32 (7) 1215-1219
35. Bruck, R. Allicin, the active component of garlic, prevents immune-mediated, concanavalin A-induced hepatic injury in mice Liver Int. 2005, 25 (3) 613-621
36. Okamoto, T. Inhibition of concanavalin A-induced mice hepatitis by coumarin derivatives Jpn. J. Pharmacol. 2001, 85 (1) 95-97
37. Yamashiki, M. Effects of the Japanese herbal medicine 'Inchinko-to' (TJ-135) on concanavalin A-induced hepatitis in mice Clin. Sci. 2000, 99 (5) 421-431
38. Kuzuhara, H. Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model Eur. J. Pharmacol. 2000, 391 (1-2) 175-181
39. Sass, G. Cytokine expression in three mouse models of experimental hepatitis Cytokine 2002, 19 (3) 115-120
40. Kesherwani, V.; Sodhi, A. Quantitative role of p42/44 and p38 in the production and regulation of cytokines TNF-α, IL-1β and IL-12 by murine peritoneal macrophages in vitro by concanavalin A Cytokine 2007, 37 (1) 62-70
41. Gong, Q. A. High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice J. Mol. Med. 2010, 88 (12) 1289-1298
42. Ojiro, K. MyD88-dependent pathway accelerates the liver damage of concanavalin A-induced hepatitis Biochem. Biophys. Res. Commun. 2010, 399 (4) 744-749
43. Ghosh, S.; Hayden, M. S. New regulators of NF-κB in inflammation Nat. Rev. Immunol. 2008, 8 (11) 837-848
44. He, G.; Karin, M. NF-κB and STAT3 - Key players in liver inflammation and cancer Cell Res. 2011, 21 (1) 159-168
45. De Keulenaer, G. W. Convergence of redox-sensitive and mitogen-activated protein kinase signaling pathways in tumor necrosis factor-α-mediated monocyte chemoattractant protein-1 induction in vascular smooth muscle cells Arterioscler., Thromb., Vasc. Biol. 2000, 20 (2) 385-391
46. Wang, X. J. B7-H4 treatment of T cells inhibits ERK, JNK, p38, and AKT activation PLoS One 2012, 10.1371/journal.pone.0028232
47. Plotnikov, A. The MAPK cascades: Signaling components, nuclear roles and mechanisms of nuclear translocation Biochim. Biophys. Acta, Mol. Cell Res. 2011, 1813 (9) 1619-1633